Monthly archive | PharmaTutor

17 June 2015

Opening for B.Pharm/B.Sc as Trainee Business Executive - Bio pharm in Novo Nordisk

Novo Nordisk is a global healthcare company with 89 years of innovation and leadership in diabetes care. The company also has leading positions within Haemophilia care, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 33,300 employees in 75 countries, and markets its products in more than 190 countries Novo Nordisk’s B shares are listed on NASDAQ OMX Copenhagen (Novo-B).

Post: Trainee Business Executive - Bio pharm

17 June 2015

Opportunity for Associate / Clinical Data Manager in inVentiv Health Clinical

inVentiv Health Clinical, a leader in drug development services, has a global infrastructure, therapeutic expertise, and commitment to quality that is unmatched in the industry. For pharmaceutical, biotechnology, generic drug, and medical device companies of all sizes around the world, inVentiv Health Clinical can help you transform promising ideas into commercial reality.

Post: Associate / Clinical Data Manager

17 June 2015

JKSSB invites Industrial Promotion Officer, Assistant Extension Officer/ Manager Industrial Estate

The Services Selection Board has been constituted in exercise of powers conferred by Provision of Section 124 of the Constitution of Jammu and Kashmir. The Rules have been made under SRO 194 of 1992 as amended upto date.

Post: Industrial Promotion Officer, Assistant Extension Officer/ Manager Industrial Estate

17 June 2015

Clinical Scientific Expert-I in Novartis

A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

Post: Clinical Scientific Expert-I

17 June 2015

Requirement for Pharmacovigilance Practice Head – IMS Health, Global Delivery Center

IMS Health is the world’s leading information, services and technology company dedicated to making healthcare perform better. By applying cutting-edge analytics and proprietary application suites hosted on the IMS One intelligent cloud, the company connects more than 10 petabytes of complex healthcare data on diseases, treatments, costs and outcomes to enable our clients to run their operations more efficiently.

Post: Pharmacovigilance Practice Head – IMS Health, Global Delivery Center (Bangalore/Gurgaon)

17 June 2015

Scientist, Advanced Genomics Applications in QIAGEN

QIAGEN enhances its portfolio with several PCR-based assay panels covering entire biological pathways and diseases, thereby strengthening its offering for pharmaceutical research. QIAGEN acquires DxS Ltd., giving the company a leadership position in personalized healthcare.

Post: Scientist, Advanced Genomics Applications

Read more about SPARC licenses Xelpros to Sun Pharma

Sun Pharma Advanced Research Company Ltd. (SPARC) has licensed out glaucoma medicine Xelpros (latanoprost BAK-free eye drops) to a subsidiary of Sun Pharma for the US market.

Read more about Single Vaccine shot of Cervarix may be sufficient to Prevent Cervical Cancer

Cervical cancer is the fourth commonest cause of cancer among women, and tragically is often diagnosed too late. Cervical cancer is a type of cancer that develops in a woman's cervix (the entrance to the womb from the vagina). It is caused by the human papillomavirus (HPV) which is easily spread by sexual intercourse. Cervarix is a vaccine against certain types of cancer-causing human papillomavirus (HPV). Currently, Cervarix, which with another vaccine, Gardasil, is being rolled out to shield young people from HPV. A new study has found that a single vaccine shot, rather than the recommended triple dose, may be enough to protect women against cervical cancer. The new research is published in the The Lancet Oncology.

16 June 2015

Work as Production Manager and Asst.Manager in Rubicon Research

Rubicon Research is a pioneer Drug Delivery Technology company in India and is recognized as a world class outsourcing partner in pharmaceutical industry. Rubicon’s proprietary technologies provide solutions for bioavailability enhancement, gastric retention, taste masking, and customising the release profiles. Rubicon has demonstrated excellence in the development of alternate dosage forms such as orally disintegrating tablets, dispersible tablets and various paediatric dosage forms.

It is USFDA and MHRA approved pharma company at Mumbai Ambernath.

Post: Production Manager and Asst.Manager

16 June 2015

Rubicon Research invites Asst.Manager-Engineering Maintenance Department

It is USFDA and MHRA approved Pharma company at Mumbai.

Post: Asst.Manager-Engineering Maintenance Department